Key result
DOAC administration immediately after UFH bolus resulted in similar rates of VTE recurrence compared to conventional therapy, but shortened hospitalization length.
Why the study?
Does direct oral anticoagulant administration immediately after an unfractionated heparin bolus reduce hospitalization length and maintain efficacy and safety compared to conventional continuous heparin therapy in patients with intermediate-high-risk pulmonary embolism?
Cohort (n=81)
No
Does direct oral anticoagulant administration immediately after an unfractionated heparin bolus reduce hospitalization length and maintain efficacy and safety compared to conventional continuous heparin therapy in patients with intermediate-high-risk pulmonary embolism?
Answers are grounded in this paper and cite their sources.
May shorten stay in intermediate-high-risk PE without excess recurrence; leaves open need for randomized confirmation before practice change.
: DOAC administration immediately after UFH bolus treatment has the same efficacy and safety, whereas hospitalization days were significantly shorter than the conventional treatment group.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2020) conducted a cohort in Intermediate-high-risk pulmonary thromboembolism (n=81). Direct oral anticoagulant (DOAC) immediately after unfractionated heparin (UFH) bolus vs. Conventional therapy (continuous intravenous UFH followed by warfarin or DOAC) was evaluated on Efficacy (recurrence of symptomatic venous thrombosis or VTE-related death) (p=1.00). DOAC administration immediately after UFH bolus resulted in similar rates of VTE recurrence compared to conventional therapy, but shortened hospitalization length.
Synapse has enriched 10 related papers. Consider them for comparative context: